nach oben

Erschienen in:

01.06.2019 | Case report

Infliximab

Elevation of liver enzymes and alopecia areata: 2 case reports

Erschienen in: Reactions Weekly | Ausgabe 1/2019

Einloggen, um Zugang zu erhalten

Excerpt

In a single-centre, retrospective review of children diagnosed with inflammatory bowel disease (IBD) between 2006 and 2018, two children [ages and sexes not stated] were described, who developed elevated liver enzymes with skin manifestations (1 patient) or alopecia areata (1 patient) following treatment with infliximab [routes, dosages, durations of treatments to reactions onsets and outcomes not stated]. …

Crowley E, et al. The evolving role of biologic therapy in paediatric very early onset inflammatory bowel disease (VEO-IBD). Journal of Pediatric Gastroenterology and Nutrition 68 (Suppl. 1): 22, May 2019. Available from: URL: http://doi.org/10.1097/MPG.0000000000002403 [abstract] - Canada

Titel: Infliximab
Elevation of liver enzymes and alopecia areata: 2 case reports
Publikationsdatum: 01.06.2019
Verlag: Springer International Publishing
Erschienen in: Reactions Weekly / Ausgabe 1/2019
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-019-64043-0

Springer Medizin

Infliximab

Elevation of liver enzymes and alopecia areata: 2 case reports

Excerpt

Weitere Artikel der Ausgabe 1/2019

Anakinra

Meropenem/tigecycline interaction

Bendamustine/brentuximab-vedotin

Amiodarone

Cotrimoxazole

Ergocalciferol

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Anakinra

Meropenem/tigecycline interaction

Bendamustine/brentuximab-vedotin

Amiodarone

Cotrimoxazole

Ergocalciferol